Showing results (31-40 of 349) with videos related to
Sort By:
Pageof 35
Clinical Neuropharmacology|December 1, 1991
Sublingual apomorphine in the treatment of Parkinson's disease complicated by motor fluctuationsA J Hughes, R Webster, M Bovingdon, et al.Archives of Neurology|August 1, 1978
Bromocriptine in parkinsonism. A long-term studyA J Lees, S Haddad, K M Shaw, et al.Journal of Clinical Psychopharmacology|August 1, 1995
The therapeutic potential of moclobemide, a reversible selective monoamine oxidase A inhibitor in Parkinson's diseaseK Sieradzan, S Channon, C Ramponi, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1994
Motor response to levodopa in patients with parkinsonian motor fluctuations: a follow-up study over three yearsA J Hughes, J P Frankel, P A Kempster, et al.British Journal of Clinical Pharmacology|October 1, 1986
The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuationsR J Hardie, S L Malcolm, A J Lees, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1989
The effects of oral protein on the absorption of intraduodenal levodopa and motor performanceJ P Frankel, P A Kempster, M Bovingdon, et al.Journal of Neural Transmission|January 1, 1978
Endocrine aspects of bromocriptine therapy in ParkinsonismK M Shaw, A J Lees, S Franks, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's diseaseP A Kempster, J P Frankel, M Bovingdon, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five yearsA J Hughes, S Bishop, B Kleedorfer, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1990
Diurnal differences in response to oral levodopaJ P Frankel, Z Pirtosek, P A Kempster, et al.Pageof 35